- Home
- EVC vs MCRB Comparison
EVC vs MCRB Comparison
Compare EVC & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- MCRB
- Stock Information
- Founded
- EVC 1996
- MCRB 2010
- Country
- EVC United States
- MCRB United States
- Employees
- EVC N/A
- MCRB N/A
- Industry
- EVC Broadcasting
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- MCRB Health Care
- Exchange
- EVC Nasdaq
- MCRB Nasdaq
- Market Cap
- EVC 188.3M
- MCRB 165.3M
- IPO Year
- EVC 2000
- MCRB 2015
- Fundamental
- Price
- EVC $2.48
- MCRB $19.36
- Analyst Decision
- EVC
- MCRB Hold
- Analyst Count
- EVC 0
- MCRB 4
- Target Price
- EVC N/A
- MCRB $73.67
- AVG Volume (30 Days)
- EVC 196.9K
- MCRB 110.8K
- Earning Date
- EVC 11-05-2025
- MCRB 08-06-2025
- Dividend Yield
- EVC 8.06%
- MCRB N/A
- EPS Growth
- EVC N/A
- MCRB N/A
- EPS
- EVC N/A
- MCRB 10.22
- Revenue
- EVC $396,704,000.00
- MCRB N/A
- Revenue This Year
- EVC $64.06
- MCRB N/A
- Revenue Next Year
- EVC N/A
- MCRB N/A
- P/E Ratio
- EVC N/A
- MCRB $1.97
- Revenue Growth
- EVC 25.34
- MCRB N/A
- 52 Week Low
- EVC $1.58
- MCRB $6.53
- 52 Week High
- EVC $2.73
- MCRB $26.40
- Technical
- Relative Strength Index (RSI)
- EVC 51.66
- MCRB 63.93
- Support Level
- EVC $2.44
- MCRB $17.82
- Resistance Level
- EVC $2.50
- MCRB $19.87
- Average True Range (ATR)
- EVC 0.08
- MCRB 1.33
- MACD
- EVC -0.00
- MCRB -0.09
- Stochastic Oscillator
- EVC 55.56
- MCRB 74.38
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.